Top compounds associated with response to CTAGE8


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.002
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.002
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.13 0.002
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.002
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC 0.26 0.002
mRNA lapatinib UHNBreast pan-cancer AAC 0.76 0.002
mRNA PD318088 CTRPv2 pan-cancer AAC 0.13 0.003
mRNA semagacestat CTRPv2 pan-cancer AAC 0.14 0.003
Download CSV